Searched for
SUN PHARMA REGULATORY FILING
NSE files DRHP for mega $3 billion IPO, SBI among 10 investors to sell stakeThe National Stock Exchange of India has filed draft papers for its initial public offering. This move positions NSE for one of the country...- HFCL bags Rs 2,666 crore telcom gear supply order from Rail Vikas Nigam for BharatNet projectHFCL has secured a significant Rs 2,666 crore order from Rail Vikas Nigam Limited. This contract is for the BharatNet Phase-3 project in Ut...
- ITR filing due dates for AY 2026-27: July 31 is not the deadline for every taxpayer; check 5 other tax filing due datesThe Income Tax Department has set July 31, 2026, as the deadline for most individual taxpayers, including the salaried class, to file their...
- $6 billion double dhamaka coming: Jio and NSE likely to file for India's biggest IPOs this weekReliance Jio and the National Stock Exchange are poised to file draft IPO papers this week, targeting a combined fundraising of approximate...
- US Stock Market: ETF issuers rush to capitalise on AI-focused ‘MANGOS’ theme after SpaceX IPOTwo asset managers are seeking regulatory approval for new ETFs tied to the "MANGOS" acronym, a basket of leading AI-focused companies incl...
- Ex-Citi exec alleges she was fired after raising Trump-related compliance concerns: ReportA former Citigroup executive claims she was fired in retaliation for flagging regulatory and compliance risks. The lawsuit alleges these co...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- NSE listing moves closer, likely to file IPO DRHP by Friday: SourceThe long-awaited NSE IPO could move a step closer this week, with the exchange expected to file its draft papers with Sebi by Friday. Value...
- ITR filing 2026: Avoid these 5 mistakes that may trigger extra tax and interest for salaried employees
- Embassy Developments awards Rs 850cr construction contract to Leighton AsiaIn a landmark deal, Embassy Developments has entrusted Leighton Asia with a contract worth over Rs 850 crore for the construction of Embass...
- Razorpay confidentially files IPO papers with SebiFintech firm Razorpay is preparing for its stock market debut. The company has confidentially filed for an initial public offering. Razorpa...
- OFCD case: SEBI moves SC against SAT relief to SICCL managers, company secretaryThe Securities and Exchange Board of India has approached the Supreme Court. This follows a Securities Appellate Tribunal order that provid...
- Regulators tighten GMP oversight of pharma plantsSeveral states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- ITR filing 2026: 9 key checks every taxpayer must make for AY 2026–27India's income tax administration has become increasingly data-driven, with information from TDS/TCS reporting, SFT filings and other sourc...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
Load More
